Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis (Q36711492)

15 August 2017

1 reference

title

Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis (English)

1 reference

15 August 2017

0 references

0 references

1 reference

Goa KL

1

1 reference

15 August 2017

McTavish D

series ordinal

2

1 reference

15 August 2017

Clissold SP

series ordinal

3

1 reference

15 August 2017

1 October 1991

1 reference

15 August 2017

1 reference

15 August 2017

42

1 reference

15 August 2017

640-658

1 reference

15 August 2017

4

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-199142040-00007

15 August 2017

0 references

cites work

The effects of ivermectin on the viability of Onchocerca lienalis microfilariae in vitro and on their subsequent development in the blackfly vector, Simulium ornatum.

1 reference

12 December 2020

The effects of ivermectin on transmission of Onchocerca volvulus

1 reference

12 December 2020

Migration and death of skin-dwelling Onchocerca volvulus microfilariae after treatment with ivermectin

1 reference

12 December 2020

The development of a laboratory model for onchocerciasis using Onchocerca gutturosa: in vitro culture, collagenase effects, drug studies and cryopreservation

1 reference

12 December 2020

Side-effects of ivermectin in treatment of onchocerciasis.

1 reference

12 December 2020

Double-blind study of ivermectin and diethylcarbamazine in African onchocerciasis patients with ocular involvement.

1 reference

12 December 2020

Impact of mass treatment of onchocerciasis with ivermectin on the transmission of infection

1 reference

12 December 2020

The effect of multiple ivermectin treatments on infection of Simulium ochraceum with Onchocerca volvulus

1 reference

12 December 2020

Lack of adverse reactions in ivermectin treatment of onchocerciasis.

1 reference

12 December 2020

Efficacy and tolerance of ivermectin in human onchocerciasis

1 reference

12 December 2020

Effect of ivermectin on the vertical distribution of Onchocerca volvulus microfilariae in the skin.

1 reference

12 December 2020

The chemotherapy of onchocerciasis. XIII. Studies with ivermectin in onchocerciasis patients in northern Ghana, a region with long lasting vector control.

1 reference

12 December 2020

[A study of ivermectin in the treatment of lymphatic filariasis due to Wuchereria bancrofti var. pacifica in French Polynesia]

1 reference

12 December 2020

Ivermectin treatment of patients with severe ocular onchocerciasis.

1 reference

12 December 2020

Changes in ocular onchocerciasis four and twelve months after community-based treatment with ivermectin in a holoendemic onchocerciasis focus

1 reference

12 December 2020

Ocular findings in a double-blind study of ivermectin versus diethylcarbamazine versus placebo in the treatment of onchocerciasis

1 reference

12 December 2020

Comparison of ivermectin and diethylcarbamazine in the treatment of onchocerciasis.

1 reference

12 December 2020

Observations on the reproductive biology of Onchocerca volvulus

1 reference

12 December 2020

The microfilaricidal activity of ivermectin in vitro and in vivo.

1 reference

12 December 2020

Emergence of Onchocerca volvulus microfilariae from skin snips before and after treatment of patients with ivermectin

1 reference

12 December 2020

On the reproductive activity of the female Onchocerca volvulus.

1 reference

12 December 2020

The efficacy of ivermectin in the chemotherapy of gastrointestinal helminthiasis in humans.

1 reference

12 December 2020

Adverse reactions in expatriates treated with ivermectin

1 reference

12 December 2020

The relative systemic availability of ivermectin after administration as capsule, tablet, and oral solution.

1 reference

12 December 2020

Effect of single-dose ivermectin therapy on human Onchocerca volvulus infection with onchocercal ocular involvement.

1 reference

12 December 2020

Clinical pharmacokinetics of anthelmintic drugs

1 reference

12 December 2020

The actions of ivermectin on cultured chick spinal cord neurons.

1 reference

12 December 2020

Onchocerca gutturosa and O. volvulus: studies on the viability and drug responses of cryopreserved adult worms in vitro

1 reference

12 December 2020

Comparative effects of anthelmintics on motility in vitro of Onchocerca gutturosa, Brugia pahangi and Acanthocheilonema viteae.

1 reference

12 December 2020

Ivermectin binds avidly to plasma proteins.

1 reference

12 December 2020

Expatriates treated with ivermectin

1 reference

12 December 2020

A double-blind comparison of the efficacy and safety of ivermectin and diethylcarbamazine in a placebo controlled study of Senegalese patients with onchocerciasis

1 reference

12 December 2020

[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. III. The tolerance and efficacy of a single oral dose of 150 mcg/kg in children]

1 reference

12 December 2020

A prospective study in high risk subjects of electrocardiographic changes with ivermectin

1 reference

12 December 2020

The effect of ivermectin on some haematological indices in rabbits: influence of vitamin K treatment

1 reference

12 December 2020

The collagenase technique: how to isolate and examine adult Onchocerca volvulus for the evaluation of drug effects

1 reference

12 December 2020

WHO Expert Committee on Onchocerciasis. Third report

1 reference

12 December 2020

Effect of mass treatment of a human population with ivermectin on transmission of Onchocerca volvulus by Simulium yahense in Liberia, West Africa.

1 reference

12 December 2020

Ivermectin effect on microfilariae of Onchocerca volvulus after a single oral dose in humans

1 reference

12 December 2020

The chemotherapy of onchocerciasis. XI. A double-blind comparative study of ivermectin, diethylcarbamazine and placebo in human onchocerciasis in northern Ghana

1 reference

12 December 2020

A community trial of ivermectin for onchocerciasis in Sierra Leone: clinical and parasitological responses to the initial dose.

1 reference

12 December 2020

Longitudinal study of lesions of the posterior segment in onchocerciasis.

1 reference

12 December 2020

A controlled trial of ivermectin and diethylcarbamazine in lymphatic filariasis.

1 reference

12 December 2020

Pregnancy outcome after inadvertent ivermectin treatment during community-based distribution

1 reference

12 December 2020

Evaluation of drugs against Onchocerca microfiliariae in an inbred mouse model.

1 reference

12 December 2020

The electrophysiology of the somatic muscle cells of Ascaris suum and Ascaridia galli.

1 reference

12 December 2020

Human onchocerciasis--an overview of the disease.

1 reference

12 December 2020

A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. I. Effect on the microfilarial reservoir and the transmission of Onchocerca volvulus

1 reference

12 December 2020

Prolongation of prothrombin time with ivermectin.

1 reference

12 December 2020

Macrolide compounds, ivermectin and milbemycin D, stimulate chloride channels sensitive to GABAergic drugs in cultured chick spinal neurons.

1 reference

12 December 2020

Dose-ranging study of ivermectin in treatment of filariasis due to Wuchereria bancrofti.

1 reference

12 December 2020

Ocular involvement in patients with onchocerciasis after repeated treatment with ivermectin.

1 reference

12 December 2020

[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. I. A comparative double-blind study of 220 patients with onchocerciasis treated with a single oral dose of 100, 150 or 200 mcg/kg

1 reference

12 December 2020

Drug activity against Onchocerca gutturosa males in vitro: a model for chemotherapeutic research on onchocerciasis

1 reference

12 December 2020

[A study in the Ivory Coast (1985-1987) of the efficacy and tolerance of ivermectin (Mectizan) in human onchocerciasis. II. Evaluation in the light of mass campaigns on the effect of yearly or half-yearly administration of single oral doses of 100,

1 reference

12 December 2020

Adverse reactions to ivermectin in reactive onchodermatitis

1 reference

12 December 2020

Ophthalmological results from a placebo controlled comparative 3-dose ivermectin study in the treatment of onchocerciasis.

1 reference

12 December 2020

Chemotherapy of Onchocerca lienalis microfilariae in mice: a model for the evaluation of novel compounds for the treatment of onchocerciasis.

1 reference

12 December 2020

Dynamics of microfilariae of Onchocerca volvulus over the first 72 hours after treatment with ivermectin.

1 reference

12 December 2020

A community trial of ivermectin in the onchocerciasis focus of Asubende, Ghana. II. Adverse reactions

1 reference

12 December 2020

Effects of multiple monthly doses of ivermectin on adult Onchocerca volvulus

1 reference

12 December 2020

Histological examination of onchocercomata after therapy with ivermectin.

1 reference

12 December 2020

Ivermectin: a long-acting microfilaricidal agent

1 reference

12 December 2020

The effects of ivermectin used in combination with other known antiparasitic drugs on adult Onchocerca gutturosa and O. volvulus in vitro.

1 reference

12 December 2020

In vitro effects of ivermectin on Onchocerca volvulus microfilariae assessed by observation and by inoculation into Simulium damnosum sensu lato.

1 reference

12 December 2020

Chemotherapy of onchocerciasis with high doses of diethylcarbamazine or a single dose of ivermectin: microfilaria levels and side effects.

1 reference

12 December 2020

Community-based treatment with ivermectin.

1 reference

12 December 2020

Expatriates treated with ivermectin

1 reference

12 December 2020

Ivermectin in loiasis and concomitant O. volvulus and M. perstans infections

1 reference

12 December 2020

Ivermectin for the treatment of Wuchereria bancrofti filariasis. Efficacy and adverse reactions

1 reference

12 December 2020

A comparison of 6-, 12-, and 24-monthly dosing with ivermectin for treatment of onchocerciasis.

1 reference

12 December 2020

Studies on the mechanism of action of avermectin B1a: stimulation of release of gamma-aminobutyric acid from brain synaptosomes.

1 reference

12 December 2020

Safety of and compliance with community-based ivermectin therapy.

1 reference

12 December 2020

Determination of ivermectin in human plasma and milk by high-performance liquid chromatography with fluorescence detection

1 reference

12 December 2020

Ivermectin for human strongyloidiasis and other intestinal helminths

1 reference

12 December 2020

Treatment of onchocerciasis. The ocular effects of ivermectin and diethylcarbamazine.

1 reference

12 December 2020

Improved high-performance liquid chromatographic method for quantitation of ivermectin in whole blood, serum or muscle tissue

1 reference

12 December 2020

10.2165/00003495-199142040-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference